Meta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer

Aliment Pharmacol Ther. 2010 Apr;31(7):708-18. doi: 10.1111/j.1365-2036.2010.04238.x. Epub 2010 Jan 18.


Background: Folic acid has been identified as a possible agent for the chemoprevention of colorectal cancer.

Aim: To assess the effectiveness of folic acid in reducing the recurrence of adenomas (precursors of colorectal cancer) among populations with a history of adenomas and the incidence of colorectal cancer within average-risk populations.

Methods: Systematic review of randomized controlled trials comparing folic acid alone, or with other agents, vs. placebo. Eight databases were searched for relevant trials. Meta-analysis was performed.

Results: The literature search retrieved 3785 citations. Six studies met the inclusion criteria. Meta-analysis of three studies in individuals with a history of adenomas showed no statistically significant difference in the relative risk of adenoma recurrence (RR 0.93, P = 0.27). A sensitivity analysis of the two higher quality trials changed the direction of effect (RR 1.16, P = 0.11). Meta-analysis of three trials in general populations demonstrated no statistically significant effect on the relative risk of colorectal cancer (RR 1.13, P = 0.54). In all three analyses, outcome event rates were higher in individuals receiving folic acid.

Conclusion: There is no evidence that folic acid is effective in the chemoprevention of colorectal adenomas or colorectal cancer for any population.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Adenoma / prevention & control*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Colorectal Neoplasms / prevention & control*
  • Folic Acid / administration & dosage
  • Folic Acid / therapeutic use*
  • Humans
  • Randomized Controlled Trials as Topic


  • Folic Acid